Cargando…
The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease
There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springhouse Corp
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434957/ https://www.ncbi.nlm.nih.gov/pubmed/28225432 http://dx.doi.org/10.1097/01.NPR.0000512253.40369.ab |
| _version_ | 1783237150577262592 |
|---|---|
| author | Bittle, Polly A. |
| author_facet | Bittle, Polly A. |
| author_sort | Bittle, Polly A. |
| collection | PubMed |
| description | There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors. |
| format | Online Article Text |
| id | pubmed-5434957 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springhouse Corp |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-54349572017-05-23 The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease Bittle, Polly A. Nurse Pract Feature: ORAL DIABETES AGENTS There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose-lowering therapies, in particular dipeptidyl peptidase-4 inhibitors. Springhouse Corp 2017-06-16 2017-02-20 /pmc/articles/PMC5434957/ /pubmed/28225432 http://dx.doi.org/10.1097/01.NPR.0000512253.40369.ab Text en The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Feature: ORAL DIABETES AGENTS Bittle, Polly A. The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease |
| title | The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease |
| title_full | The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease |
| title_fullStr | The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease |
| title_full_unstemmed | The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease |
| title_short | The use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease |
| title_sort | use of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease |
| topic | Feature: ORAL DIABETES AGENTS |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5434957/ https://www.ncbi.nlm.nih.gov/pubmed/28225432 http://dx.doi.org/10.1097/01.NPR.0000512253.40369.ab |
| work_keys_str_mv | AT bittlepollya theuseofdipeptidylpeptidase4inhibitorsinpatientswithtype2diabeteschronickidneydisease AT bittlepollya useofdipeptidylpeptidase4inhibitorsinpatientswithtype2diabeteschronickidneydisease |